DystoniaBoTXNet: Novel Neural Network Biomarker of Botulinum Toxin Efficacy in Isolated Dystonia is a research paper published in Annals of Neurology (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Neurological Disorders and Stroke
Grant: R01NS088160
National Institute of Neurological Disorders and Stroke
Grant: R01NS124228
National Institute on Deafness and Other Communication Disorders
Grant: R01DC011805
National Institute on Deafness and Other Communication Disorders
Grant: R01DC012545
NIDCD NIH HHS
Grant: P50 DC019900
National Institutes of Health
Grant: 5R01NS124228-02
Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia
National Institutes of Health
Grant: 5P50DC019900-02
Next-generation clinical phenotyping and pathophysiology of laryngeal dystonia and voice tremor
National Institutes of Health
Grant: 5R01DC012545-10
Central mechanisms and treatment response of sodium oxybate in spasmodic dysphonia and voice tremor
National Institutes of Health
Grant: 4R01DC011805-05
Imaging genetics of spasmodic dysphonia
National Institutes of Health
Grant: 1R01NS088160-01A1
Brain networks in dystonia
FWCI
0.94
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals